Table 1.
Issues | Key considerations or questions | Available options (indicative) | |
Before data collection | |||
Defining the activity | Does the activity constitute research, M&E, and/or surveillance? | Nature of activity is defined by independent persons | |
Who defines the nature of the activity? | Criteria to distinguish types of MPSb are established and applied | ||
What ethical requirements follow? IRBa or other review? Disclosures or authorizations? Transformation of data into policy, practice? |
|||
Stakeholder engagement | What are the ethical goals of engagement? | Identify local norms and practices associated with the use of mobile phones | |
Who should be engaged? | Determine the social, cultural, legal, and public health significance of the information being collected | ||
How and when should stakeholders be engaged? | Identify stakeholders, for example, technical experts, community representatives, health system agents, donor agency representatives | ||
Appropriate design | How should the survey be delivered? What qualities of survey delivery will affect the respondent and data validity? What are the consequences of: IVRc or CATId or SMSe or mixed modality? Will the survey reach minority, disadvantaged, marginalized groups? |
Align delivery method with population characteristics, for example, if low literacy, IVR may be preferred | |
Does the delivery method influence social desirability bias? | Use all major languages commonly used in other traditional surveys | ||
Linguistic strategy: how many and which languages ought to be used to administer the survey? | |||
Anticipating potential harms and benefits | What are the potential burdens or risks of participating in a MPS program (at the individual, community, national levels)? For example, Sensitive information and stigma |
User-testing, interviews, and focus groups to identify key sensitive issues and design survey taking these into account | |
What are the potential benefits or advantages of participating in a MPS program (at the individual, community, national levels)? For example, More frequent, less costly information, and better NCDf care |
|||
What strategies will minimize harms and maximize benefits? | |||
How will harms or benefits be balanced for disadvantaged and marginalized groups? | |||
During data collection | |||
Consent | What information about the MPS should be disclosed to respondents? | Disclose information consistent with basic consent elements | |
How should respondents authorize their participation? | Review local practices, population preferences, and legal permissibility of different opt-in or opt-out approaches | ||
Should types of disclosure and authorization differ based on the MPS delivery method (IVR or CATI or SMS or mixed modality) and population? | |||
Reaching intended respondents | Which MPS sampling and recruitment methods best reduce unnecessary burdens upon intended and unintended MPS recipients? | Take stock of other existing survey approaches in designing MPS delivery strategies | |
What approach to MPS incentive delivery is most appropriate? | Conduct follow up surveys by human caller on limited sample to verify | ||
Are existing laws likely to make it difficult to reach respondents using MPS? | Consult local regulatory authorities to identify and address potential areas of concern | ||
After data collection | |||
Data ownership, access and use | To whom do the data belong? | Establish advance agreements to guide terms of data ownership, access, and use | |
What data can be shared? | Consider restrictions on data access and use for purposes that do not advance public health | ||
Who should have access to the data? | |||
How should the data be shared? | |||
To what uses can the data be put? | |||
Ensuring LMICg sustainability | What are different actors’ responsibilities to promote and advance local sustainability? | Agree upon sustainability and capacity development commitments in advance | |
Who is responsible for deciding who is allocated which strategies to undertake? | Identify core areas of local need and strength | ||
Should ongoing MPS efforts be supported only in the original data collection area or more broadly? | Integrate with existing programs and approaches where available |
aIRB: institutional review board.
bMPS: mobile phone survey.
cIVR: interactive voice response.
dCATI: computer-assisted telephone interview.
eSMS: short message service.
fNCD: noncommunicable disease.
gLMIC: low- and middle-income country.